530057 — Vivanza Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Vivanza Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	-27.8	-30.9	0.551	1.41	1.67
Net Total Accounts Receivable
Net Total Receivables	108	73.1	97.7	166	132
Total Inventory
Total Other Current Assets
Total Current Assets	91.4	50.1	125	196	157
Net Property, Plant And Equipment	6.78	6.9	6.82	6.79	7.05
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	124	84.5	156	225	195
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	90.6	52.9	94.7	170	122
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	92.7	52.9	121	184	149
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	30.8	31.6	34.9	40.9	46.4
Total Liabilities & Shareholders' Equity	124	84.5	156	225	195
Total Common Shares Outstanding